Thompson Siegel & Walmsley LLC Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Thompson Siegel & Walmsley LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 68.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,424 shares of the healthcare conglomerate’s stock after buying an additional 981 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in UnitedHealth Group were worth $1,226,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth $341,000. Principal Financial Group Inc. lifted its position in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. Lifeworks Advisors LLC lifted its position in shares of UnitedHealth Group by 21.4% during the third quarter. Lifeworks Advisors LLC now owns 1,446 shares of the healthcare conglomerate’s stock worth $845,000 after purchasing an additional 255 shares during the last quarter. Oak Harbor Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 7.4% in the third quarter. Oak Harbor Wealth Partners LLC now owns 1,869 shares of the healthcare conglomerate’s stock valued at $1,093,000 after acquiring an additional 128 shares in the last quarter. Finally, Broderick Brian C raised its holdings in shares of UnitedHealth Group by 0.5% in the third quarter. Broderick Brian C now owns 21,497 shares of the healthcare conglomerate’s stock valued at $12,569,000 after acquiring an additional 100 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $488.52 on Friday. The business’s 50 day moving average price is $511.36 and its 200 day moving average price is $550.33. The firm has a market cap of $446.85 billion, a P/E ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.